{"paper_id":"98085b0e-dde6-4a04-96e1-06446438c64d","body_text":"Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.\nResolution of pelvic pain related to adenomyosis following treatment with dextroamphetamine sulfate\nAffiliations\nArticle Info\n1 Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ\n2 Cooper Institute for Reproductive Hormonal Disorders, P.C. Mt. Laurel, NJ (USA)\nAbstract\nPurpose: To determine if treatment with dextroamphetamine sulfate can reduce pelvic pain that was attributed to adenomyosis. Materials and Methods: Dextroamphetamine sulfate was given to a 32-year-old woman who suffered on a daily basis from severe chronic pelvic pain that was not relieved by laparoscopic removal of endometriosis by oral contraceptive and ibuprofen. The adenomyosis was diagnosed by magnetic resonance imaging. Results: Within three months the pain was completely gone and has remained absent for six months. Conclusions: Dextroamphetamine sulfate relieved pain from adenomyosis similar to its effect on endometriosis.\nKeywords\n- Adenomyosis\n- Chronic pelvic pain\n- Dextroamphetamine sulfate\n- Endometriosis\n- Sympathetic hypofunction","source_license":"CC0","license_restricted":false}